+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nociceptin Receptor"

Nociceptin receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Nociceptin receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Nociceptin Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Nociceptin Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • October 2024
  • 78 Pages
  • Global
From
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 57 Pages
  • Global
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
Opioid Hormones. Vitamins and Hormones Volume 111 - Product Thumbnail Image

Opioid Hormones. Vitamins and Hormones Volume 111

  • Book
  • August 2019
  • 5 Results (Page 1 of 1)
Loading Indicator

The Nociceptin Receptor is a G-protein coupled receptor that is involved in the modulation of pain. It is a target for the development of analgesic drugs, which are used to treat pain. Analgesics that target the Nociceptin Receptor are thought to be more effective than traditional analgesics, as they are able to target the source of the pain more precisely. This has led to the development of a number of Nociceptin Receptor-targeting drugs, such as Naloxone, Naltrexone, and Naloxegol. These drugs are used to treat a variety of pain conditions, including chronic pain, neuropathic pain, and cancer pain. The Nociceptin Receptor market is an emerging market, with a number of companies developing drugs to target the receptor. These companies include AstraZeneca, Merck, Pfizer, and Johnson & Johnson. Show Less Read more